Demarche S, et al. - This investigation was conducted to evaluate the proportion of non-eosinophilic asthmatics in whom inhaled corticosteroids (ICS) may be withdrawn without any clinical degradation. The predictive markers of a failure to stop treatment with ICS in this population were also determined. Irrespective of baseline asthma control, it was feasible to withdraw or attenuate the dose of ICS in two-thirds of non-eosinophilic asthmatics. Furthermore, an elevated blood eosinophil count may predict the failure to stop ICS.